These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 31301533)

  • 1. Determining the impact of Benzathine penicillin G prophylaxis in children with latent rheumatic heart disease (GOAL trial): Study protocol for a randomized controlled trial.
    Beaton A; Okello E; Engelman D; Grobler A; Scheel A; DeWyer A; Sarnacki R; Omara IO; Rwebembera J; Sable C; Steer A
    Am Heart J; 2019 Sep; 215():95-105. PubMed ID: 31301533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intramuscular versus enteral penicillin prophylaxis to prevent progression of rheumatic heart disease: Study protocol for a noninferiority randomized trial (the GOALIE trial).
    Rwebembera J; Ndagire E; Carvalho N; Webel AR; Sable C; Okello E; Sarnacki R; Spaziani AM; Mucunguzi A; Engelman D; Grobler A; Steer A; Beaton A
    Am Heart J; 2024 Sep; 275():74-85. PubMed ID: 38797460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary Antibiotic Prophylaxis for Latent Rheumatic Heart Disease.
    Beaton A; Okello E; Rwebembera J; Grobler A; Engelman D; Alepere J; Canales L; Carapetis J; DeWyer A; Lwabi P; Mirabel M; Mocumbi AO; Murali M; Nakitto M; Ndagire E; Nunes MCP; Omara IO; Sarnacki R; Scheel A; Wilson N; Zimmerman M; Zühlke L; Karthikeyan G; Sable CA; Steer AC
    N Engl J Med; 2022 Jan; 386(3):230-240. PubMed ID: 34767321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term antibiotic prophylaxis for prevention of rheumatic fever recurrence and progression to rheumatic heart disease.
    Bray JJ; Thompson S; Seitler S; Ali SA; Yiu J; Salehi M; Ahmad M; Pelone F; Gashau H; Shokraneh F; Ahmed N; Cassandra M; Marijon E; Celermajer DS; Providencia R
    Cochrane Database Syst Rev; 2024 Sep; 9(9):CD015779. PubMed ID: 39312290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Latent Rheumatic Heart Disease: Identifying the Children at Highest Risk of Unfavorable Outcome.
    Beaton A; Aliku T; Dewyer A; Jacobs M; Jiang J; Longenecker CT; Lubega S; McCarter R; Mirabel M; Mirembe G; Namuyonga J; Okello E; Scheel A; Tenywa E; Sable C; Lwabi P
    Circulation; 2017 Dec; 136(23):2233-2244. PubMed ID: 28972003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adequate adherence to benzathine penicillin secondary prophylaxis following the diagnosis of rheumatic heart disease by echocardiographic screening.
    Culliford-Semmens N; Tilton E; Webb R; Lennon D; Paku B; Malcolm J; French S; Blair N; Wilson N
    N Z Med J; 2017 Jun; 130(1457):50-57. PubMed ID: 28617789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary prevention of rheumatic heart disease in Ethiopia: a multicenter study.
    Belay W; Dessie A; Ahmed H; Gedlu E; Mariyo A; Shehibo A; Tigabu Z; Aliyu MH; Soslow J
    BMC Cardiovasc Disord; 2022 Feb; 22(1):26. PubMed ID: 35109807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzathine penicillin adherence for secondary prophylaxis among patients affected with rheumatic heart disease attending Mulago Hospital.
    Musoke C; Mondo CK; Okello E; Zhang W; Kakande B; Nyakoojo W; Freers J
    Cardiovasc J Afr; 2013 May; 24(4):124-9. PubMed ID: 24217043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement in rheumatic fever and rheumatic heart disease management and prevention using a health centre-based continuous quality improvement approach.
    Ralph AP; Fittock M; Schultz R; Thompson D; Dowden M; Clemens T; Parnaby MG; Clark M; McDonald MI; Edwards KN; Carapetis JR; Bailie RS
    BMC Health Serv Res; 2013 Dec; 13():525. PubMed ID: 24350582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The personal and clinical impact of screen-detected maternal rheumatic heart disease in Uganda: a prospective follow up study.
    Voleti S; Okello E; Murali M; Sarnacki R; Majwala A; Ssembatya R; Bakka O; Namisanvu H; Njeri A; Matovu A; DeStigter K; Sable C; Beaton A
    BMC Pregnancy Childbirth; 2020 Oct; 20(1):611. PubMed ID: 33036571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of latent rheumatic heart disease: External validation of a simplified score in patients with and without secondary prophylaxis.
    Nascimento BR; Nunes MCP; da Silva JLP; Steer A; Engelman D; Okello E; Rwebembera J; Zuhlke L; Mirabel M; Nakitto M; Sarnacki R; Ribeiro ALP; Sable CA; Beaton AZ;
    Int J Cardiol; 2024 Mar; 399():131662. PubMed ID: 38141728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to secondary prevention of rheumatic fever and rheumatic heart disease in young people: an 11-year retrospective study.
    Liaw J; Gorton S; Heal C; White A
    Aust N Z J Public Health; 2022 Dec; 46(6):758-763. PubMed ID: 35616403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A qualitative examination of secondary prophylaxis in rheumatic heart disease: factors influencing adherence to secondary prophylaxis in Uganda.
    Huck DM; Nalubwama H; Longenecker CT; Frank SH; Okello E; Webel AR
    Glob Heart; 2015 Mar; 10(1):63-69.e1. PubMed ID: 25754568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rheumatic heart disease in Timor-Leste school students: an echocardiography-based prevalence study.
    Davis K; Remenyi B; Draper AD; Dos Santos J; Bayley N; Paratz E; Reeves B; Appelbe A; Cochrane A; Johnson TD; Korte LM; Do Rosario IM; Da Silva Almeida IT; Roberts KV; Carapetis JR; Francis JR
    Med J Aust; 2018 Apr; 208(7):303-307. PubMed ID: 29642817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to secondary antibiotic prophylaxis for patients with rheumatic heart disease diagnosed through screening in Fiji.
    Engelman D; Mataika RL; Kado JH; Ah Kee M; Donath S; Parks T; Steer AC
    Trop Med Int Health; 2016 Dec; 21(12):1583-1591. PubMed ID: 27730711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving delivery of secondary prophylaxis for rheumatic heart disease in remote Indigenous communities: study protocol for a stepped-wedge randomised trial.
    Ralph AP; Read C; Johnston V; de Dassel JL; Bycroft K; Mitchell A; Bailie RS; Maguire GP; Edwards K; Currie BJ; Kirby A; Carapetis JR
    Trials; 2016 Jan; 17():51. PubMed ID: 26818484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How accurate is the diagnosis of rheumatic fever in Egypt? Data from the national rheumatic heart disease prevention and control program (2006-2018).
    Ghamrawy A; Ibrahim NN; Abd El-Wahab EW
    PLoS Negl Trop Dis; 2020 Aug; 14(8):e0008558. PubMed ID: 32804953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High risk of early sub-therapeutic penicillin concentrations after intramuscular benzathine penicillin G injections in Ethiopian children and adults with rheumatic heart disease.
    Ketema EB; Gishen NZ; Hailu A; Leul A; Hadgu A; Hagos K; Berhane S; Tsega T; Page-Sharp M; Davis TM; Moore B; Batty KT; Carapetis J; Salman S; Manning L
    PLoS Negl Trop Dis; 2021 Jun; 15(6):e0009399. PubMed ID: 34115748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A population pharmacokinetic study of benzathine benzylpenicillin G administration in children and adolescents with rheumatic heart disease: new insights for improved secondary prophylaxis strategies.
    Hand RM; Salman S; Newall N; Vine J; Page-Sharp M; Bowen AC; Gray K; Baker A; Kado J; Joseph J; Marsh J; Ramsay J; Sika-Paotonu D; Batty KT; Manning L; Carapetis J
    J Antimicrob Chemother; 2019 Jul; 74(7):1984-1991. PubMed ID: 30989171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rheumatic heart disease in The Gambia: clinical and valvular aspects at presentation and evolution under penicillin prophylaxis.
    Jaiteh LES; Drammeh L; Anderson ST; Mendy J; Ceesay S; D'Alessandro U; Carapetis J; Mirabel M; Erhart A
    BMC Cardiovasc Disord; 2021 Oct; 21(1):503. PubMed ID: 34663206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.